News & Views
AI Investors Hesitate Despite Market Growth
As the world is facing threats of a major recession in the slipstream of the Covid-19 pandemic, the AI drug development industry is caught in a limbo with hesitating ...
Investors Double Down on AI Drug Development
Funding for artificial intelligence in drug development hit $4.1B in 2021, a 36% increase from the year before. The AI drug development industry has gained a lot of attention ...
Canada’s Early Focus on Artificial Intelligence is Starting to Reap Commercial Benefits
Canada’s early contributions and long-standing expertise in artificial intelligence (AI) have proven valuable when it comes to AI applications in drug development. After several years where the industry has ...
AI Drug Development Market Projected to Reach $5.1 Billion by 2025
The world market for AI applications in drug development is projected to reach $5.1 billion by 2025 with a CAGR of 29.6%, an increase of over $3.6 billion from ...
AI Business: AI-based drug development startups have raised $2.1bn in the past six months
Startups that apply AI in drug development have raised a staggering $2.1 billion in H1 this year – with 2021 set to be a “landmark year” for AI in ...
The Science Advisory Board: AI drug development startups raised $2.1B in 1st half of 2021
The market for artificial intelligence (AI) in drug development and discovery has been red-hot in recent years. The potential impact that AI can offer to human health and pharmaceutical ...
AI Drug Development Startups Raised $2.1B in H1 2021
The market for artificial intelligence in drug development and discovery has been one of the most hyped in recent years. The potential impact this industry can offer to human ...
The Science Advisory Board: Royalties Challenge Risk and Reward in AI Drug Development
As artificial intelligence (AI) becomes increasingly important for drug development, how should AI firms -- many of which are small startups -- structure their business relationships with pharmaceutical companies? ...
Royalties Challenge Risk and Reward in AI Drug Development
Royalties on sales are by no means new in AI drug development, but as the industry matures this component of the deals will play a bigger role and drive ...
Charles River Acquired Distributed Bio – Here’s What it Means for the AI Ecosystem
2020 was a great year for AI in drug development where the total investment in the industry hit $9.2B and many partnerships between AI specialists and the pharmaceutical industry ...
Featured in The Science Advisory Board: How is the pharma-AI partnership landscape changing?
2020 was a great year for artificial intelligence (AI) in drug development, where the total investment in the industry hit $9.2 billion and many partnerships between AI specialists and the ...
Featured in Yahoo Finance: AI Drug Development Investments Accelerated in 2020
The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the ...
Featured in Morningstar: AI Drug Development Investments Accelerated in 2020
The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the ...
AI in Drug Development Investments Accelerated in 2020
The market for AI in Drug Development had a record year in 2020 with $2.9B new funding and a total funding in the industry reaching $9.2B. But while the ...